Fig 1.
Bar graph of the relative abundance at the phyla level of BPH5 mice with fenbendazole treatment.
Fig 2.
Differences at the phyla level of BPH5 male and females pre and post fenbendazole treatment.
A). Relative abundance at the phyla level of the BPH5 male pre and post-treatment. B). Relative abundance at the phyla level of the BPH5 female pre and post-treatment. C). Ratio of Firmicutes to Bacteroidetes in BPH/5 male and females. D). Changes in Verrucomicrobia pre and post fenbendazole treatment in male and female BPH/5 mice. E). Changes in Actinobacteria pre and post fenbendazole treatment in male and female BPH/5 mice.
Fig 3.
A.) Alpha diversity of BPH5 mice treated with Fenbendazole B.) Principal coordinate analysis of Bray-Curtis dissimilarity matrix of BPH5 mice treated with Fenbendazole.
Fig 4.
Top 6 changes at ASV level in a sex dependent manner A). Changes found with fenbendazole treatment at the ASV level in BPH5 male. B). Changes found with fenbendazole treatment at the ASV level in BPH5 female.